BSE: NATCOPHARM - NATCO Pharma Limited

六个月盈利: -2.66%
股息率: +0.81%

促销时间表 NATCO Pharma Limited


关于公司 NATCO Pharma Limited

NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care.

更多详情
The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

ISIN INE987B01026
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.5089
Дивиденд ао 4.5
Сайт https://www.natcopharma.co.in
Цена ао 1212.35
每日价格变化: +2.85% (1212.35)
每周价格变化: -6% (1326.6)
每月价格变化: -13.51% (1441.75)
3个月内价格变化: -10.34% (1390.75)
六个月内的价格变化: -2.66% (1281.05)
每年价格变化: +47.18% (847.2)
3年内价格变化: +35.35% (921.25)
5年内价格变化: +111.9% (588.45)
10年价格变化: 0% (1246.95)
年初以来价格变化: -14.79% (1463.45)

低估

姓名 意义 年级
P/S 4.26 4
P/BV 2.91 6
P/E 12.27 8
EV/EBITDA 9.66 8
全部的: 7.38

效率

姓名 意义 年级
ROA, % 22.1 7
ROE, % 25.88 8
全部的: 6

股息

姓名 意义 年级
Div yield, % 0.8057 2.03
DSI 0.8571 8.57
全部的: 2.82

责任

姓名 意义 年级
Debt/EBITDA 0.1605 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 111.82 10
盈利能力 Ebitda, % 12.83 2
盈利能力 EPS, % 206.73 10
全部的: 8.4

导师 职称 支付 出生年份
Mr. Rajeev Nannapaneni CEO & Vice Chairman N/A 1977 (48 年)
Mr. S. V. V. N. Appa Rao Chief Financial Officer N/A
Dr. Donthineni Linga Rao M.D. President of Technical Affairs & Whole Time Director N/A 1952 (73 年)
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS. MD & Chairman N/A 1945 (80 年)
Mr. Potluri Sivaramakrishna Prasad Executive VP of Corporate Engineering Services & Whole Time Director N/A 1958 (67 年)
Mr. Chekuri Venkat Ramesh C.S. Company Secretary & Compliance Officer 3M
Dr. Pavan Ganapati Bhat Executive VP of Technical Operations & Director N/A 1967 (58 年)
N. Sadasiva Rao Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management N/A
James Rajakumar Vice President of Marketing & Sales - Domestic N/A
Nadella Malleswara Rao VP & Head of Operations

地址: India, Hyderabad, Natco House - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.natcopharma.co.in